

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.59154489 |
| 2 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.59154489 |
| 3 | modulation by symbiont of host immune response (GO:0052553) | 6.59154489 |
| 4 | positive regulation by symbiont of host defense response (GO:0052509) | 6.59154489 |
| 5 | modulation by symbiont of host defense response (GO:0052031) | 6.59154489 |
| 6 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.59154489 |
| 7 | neutrophil activation involved in immune response (GO:0002283) | 5.92911963 |
| 8 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.86129853 |
| 9 | cellular extravasation (GO:0045123) | 5.65674207 |
| 10 | macrophage activation involved in immune response (GO:0002281) | 5.51580658 |
| 11 | response to peptidoglycan (GO:0032494) | 5.51357842 |
| 12 | microglial cell activation (GO:0001774) | 5.24527997 |
| 13 | leukocyte aggregation (GO:0070486) | 5.09558514 |
| 14 | respiratory burst (GO:0045730) | 5.04491060 |
| 15 | response to host immune response (GO:0052572) | 4.97984511 |
| 16 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.97984511 |
| 17 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.95850419 |
| 18 | neutrophil mediated immunity (GO:0002446) | 4.81805947 |
| 19 | neutrophil activation (GO:0042119) | 4.81325176 |
| 20 | granulocyte activation (GO:0036230) | 4.60373496 |
| 21 | response to host (GO:0075136) | 4.56939831 |
| 22 | response to host defenses (GO:0052200) | 4.56939831 |
| 23 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 4.56939831 |
| 24 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.52649539 |
| 25 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.49132193 |
| 26 | detection of bacterium (GO:0016045) | 4.44072386 |
| 27 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.42816917 |
| 28 | negative regulation of cell killing (GO:0031342) | 4.42816917 |
| 29 | immunoglobulin mediated immune response (GO:0016064) | 4.26333922 |
| 30 | production of molecular mediator involved in inflammatory response (GO:0002532) | 4.25787534 |
| 31 | superoxide anion generation (GO:0042554) | 4.25392717 |
| 32 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.20334589 |
| 33 | regulation of mast cell degranulation (GO:0043304) | 4.16761485 |
| 34 | myeloid cell activation involved in immune response (GO:0002275) | 4.03599611 |
| 35 | macrophage activation (GO:0042116) | 4.01772142 |
| 36 | positive regulation of mast cell activation (GO:0033005) | 4.00177926 |
| 37 | neutrophil chemotaxis (GO:0030593) | 3.99354261 |
| 38 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.92989926 |
| 39 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.92881286 |
| 40 | regulation of hypersensitivity (GO:0002883) | 3.91249868 |
| 41 | regulation of mast cell activation (GO:0033003) | 3.90025492 |
| 42 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.89274938 |
| 43 | neutrophil migration (GO:1990266) | 3.88000247 |
| 44 | negative regulation of granulocyte differentiation (GO:0030853) | 3.86767377 |
| 45 | regulation of gamma-delta T cell activation (GO:0046643) | 3.85834349 |
| 46 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.81838579 |
| 47 | positive regulation of mast cell degranulation (GO:0043306) | 3.81838579 |
| 48 | response to muramyl dipeptide (GO:0032495) | 3.81579690 |
| 49 | regulation of leukocyte degranulation (GO:0043300) | 3.81380674 |
| 50 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.80294081 |
| 51 | response to fungus (GO:0009620) | 3.74463634 |
| 52 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.68493586 |
| 53 | positive regulation of B cell differentiation (GO:0045579) | 3.65486506 |
| 54 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.64262792 |
| 55 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.64223239 |
| 56 | positive regulation of interferon-alpha production (GO:0032727) | 3.63225299 |
| 57 | detection of biotic stimulus (GO:0009595) | 3.60526485 |
| 58 | myeloid leukocyte mediated immunity (GO:0002444) | 3.58386238 |
| 59 | granulocyte chemotaxis (GO:0071621) | 3.56590865 |
| 60 | regulation of tolerance induction (GO:0002643) | 3.56311453 |
| 61 | mast cell activation (GO:0045576) | 3.53824619 |
| 62 | granulocyte migration (GO:0097530) | 3.51147496 |
| 63 | negative regulation of interleukin-12 production (GO:0032695) | 3.50182172 |
| 64 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.45302320 |
| 65 | regulation of interferon-alpha production (GO:0032647) | 3.42678518 |
| 66 | positive regulation of antigen processing and presentation (GO:0002579) | 3.39545569 |
| 67 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.39501424 |
| 68 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.37187141 |
| 69 | regulation of T cell tolerance induction (GO:0002664) | 3.35305201 |
| 70 | negative regulation of interleukin-17 production (GO:0032700) | 3.33655126 |
| 71 | positive regulation of regulated secretory pathway (GO:1903307) | 3.31668690 |
| 72 | reactive oxygen species biosynthetic process (GO:1903409) | 3.30747368 |
| 73 | leukotriene metabolic process (GO:0006691) | 3.30026357 |
| 74 | negative regulation of T cell mediated immunity (GO:0002710) | 3.29948356 |
| 75 | regulation of B cell differentiation (GO:0045577) | 3.29798921 |
| 76 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.23721061 |
| 77 | macrophage differentiation (GO:0030225) | 3.22909305 |
| 78 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.20040837 |
| 79 | positive regulation of chemokine secretion (GO:0090197) | 3.17887203 |
| 80 | defense response to fungus (GO:0050832) | 3.16212715 |
| 81 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.16123345 |
| 82 | myeloid leukocyte activation (GO:0002274) | 3.13079032 |
| 83 | detection of other organism (GO:0098543) | 3.12025130 |
| 84 | regulation of regulated secretory pathway (GO:1903305) | 3.12009548 |
| 85 | leukocyte mediated cytotoxicity (GO:0001909) | 3.11545537 |
| 86 | positive regulation of leukocyte degranulation (GO:0043302) | 3.10762007 |
| 87 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.10296467 |
| 88 | I-kappaB phosphorylation (GO:0007252) | 3.08422806 |
| 89 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.07621369 |
| 90 | leukocyte cell-cell adhesion (GO:0007159) | 3.05751610 |
| 91 | pinocytosis (GO:0006907) | 3.05244653 |
| 92 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.04076867 |
| 93 | positive thymic T cell selection (GO:0045059) | 3.03283297 |
| 94 | detection of molecule of bacterial origin (GO:0032490) | 3.03191099 |
| 95 | response to protozoan (GO:0001562) | 3.02536037 |
| 96 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.01971379 |
| 97 | negative regulation of interleukin-6 production (GO:0032715) | 3.00756628 |
| 98 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.97976761 |
| 99 | B cell mediated immunity (GO:0019724) | 2.97491606 |
| 100 | B cell receptor signaling pathway (GO:0050853) | 2.96201556 |
| 101 | negative regulation of mast cell activation (GO:0033004) | 2.95303116 |
| 102 | T-helper 1 type immune response (GO:0042088) | 2.93511257 |
| 103 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.92857091 |
| 104 | myeloid leukocyte migration (GO:0097529) | 2.90441842 |
| 105 | phagosome maturation (GO:0090382) | 2.88060867 |
| 106 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.87730860 |
| 107 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.86522262 |
| 108 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.85171263 |
| 109 | cytokine secretion (GO:0050663) | 2.83951413 |
| 110 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.83287924 |
| 111 | positive regulation of interleukin-17 production (GO:0032740) | 2.83176047 |
| 112 | leukocyte chemotaxis (GO:0030595) | 2.82608859 |
| 113 | germinal center formation (GO:0002467) | 2.82545826 |
| 114 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.82215382 |
| 115 | cellular response to interferon-gamma (GO:0071346) | 2.81638057 |
| 116 | T cell migration (GO:0072678) | 2.81377843 |
| 117 | regulation of antigen processing and presentation (GO:0002577) | 2.81342922 |
| 118 | defense response to protozoan (GO:0042832) | 2.80923104 |
| 119 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.80539123 |
| 120 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.79071432 |
| 121 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.78404989 |
| 122 | cell wall macromolecule catabolic process (GO:0016998) | 2.78146767 |
| 123 | leukocyte degranulation (GO:0043299) | 2.77239918 |
| 124 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.77222826 |
| 125 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.76905270 |
| 126 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.76105892 |
| 127 | negative regulation of interleukin-1 production (GO:0032692) | 2.73759235 |
| 128 | dendritic cell migration (GO:0036336) | 2.73588050 |
| 129 | lipoxygenase pathway (GO:0019372) | 2.72604948 |
| 130 | detection of external biotic stimulus (GO:0098581) | 2.72458469 |
| 131 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.72314381 |
| 132 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.72268558 |
| 133 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.72067085 |
| 134 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.72067085 |
| 135 | phagocytosis, engulfment (GO:0006911) | 2.70623039 |
| 136 | cellular defense response (GO:0006968) | 2.70006610 |
| 137 | sequestering of metal ion (GO:0051238) | 2.69668700 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.59233734 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.15775326 |
| 3 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.71286256 |
| 4 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.66826514 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.48447864 |
| 6 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 4.15477488 |
| 7 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.89397382 |
| 8 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.78845343 |
| 9 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.61162499 |
| 10 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.57574639 |
| 11 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.38035272 |
| 12 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.15758767 |
| 13 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.12757958 |
| 14 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.99790628 |
| 15 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.82463919 |
| 16 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.80288786 |
| 17 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.73591404 |
| 18 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.72881949 |
| 19 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.66075811 |
| 20 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.54207110 |
| 21 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.41526152 |
| 22 | * SPI1_23127762_ChIP-Seq_K562_Human | 2.37398372 |
| 23 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.32035272 |
| 24 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.24504078 |
| 25 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.15732479 |
| 26 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.15162870 |
| 27 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.14202010 |
| 28 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.11950238 |
| 29 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.07781226 |
| 30 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.07047742 |
| 31 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.04939865 |
| 32 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 2.04104586 |
| 33 | PU_27001747_Chip-Seq_BMDM_Mouse | 2.00927514 |
| 34 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.00247058 |
| 35 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.95249103 |
| 36 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.93229613 |
| 37 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.89340618 |
| 38 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.84346003 |
| 39 | MYB_26560356_Chip-Seq_TH2_Human | 1.80987746 |
| 40 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.77065926 |
| 41 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.76817222 |
| 42 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.74664550 |
| 43 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.65508720 |
| 44 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.64983828 |
| 45 | MAF_26560356_Chip-Seq_TH1_Human | 1.59941068 |
| 46 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.57030777 |
| 47 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.54765429 |
| 48 | MYB_26560356_Chip-Seq_TH1_Human | 1.53868958 |
| 49 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.51651866 |
| 50 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.51373406 |
| 51 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.51125500 |
| 52 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.50156634 |
| 53 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45104038 |
| 54 | UTX_26944678_Chip-Seq_JUKART_Human | 1.41695551 |
| 55 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.34093117 |
| 56 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.33995508 |
| 57 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.31144287 |
| 58 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.29225406 |
| 59 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.26274966 |
| 60 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.26189275 |
| 61 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.25251948 |
| 62 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.24835815 |
| 63 | GATA3_26560356_Chip-Seq_TH2_Human | 1.24627678 |
| 64 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.23074850 |
| 65 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.20852557 |
| 66 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.20463889 |
| 67 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.19632603 |
| 68 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.19028551 |
| 69 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.16788374 |
| 70 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.13792803 |
| 71 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.13453504 |
| 72 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.12833129 |
| 73 | MYC_22102868_ChIP-Seq_BL_Human | 1.08899049 |
| 74 | GATA2_19941826_ChIP-Seq_K562_Human | 1.06079386 |
| 75 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.05604854 |
| 76 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05227165 |
| 77 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05049070 |
| 78 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04592453 |
| 79 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.02469215 |
| 80 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.01419061 |
| 81 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.99893954 |
| 82 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.98722860 |
| 83 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.98559964 |
| 84 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.98411131 |
| 85 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.97526902 |
| 86 | P300_27268052_Chip-Seq_Bcells_Human | 0.94562808 |
| 87 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.94368245 |
| 88 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.93088744 |
| 89 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.92065883 |
| 90 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.91044204 |
| 91 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90790615 |
| 92 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.87337014 |
| 93 | GATA1_19941826_ChIP-Seq_K562_Human | 0.86020547 |
| 94 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.84952301 |
| 95 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.83555875 |
| 96 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.82880741 |
| 97 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.80269938 |
| 98 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.79610165 |
| 99 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.79498241 |
| 100 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.79407549 |
| 101 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.78665996 |
| 102 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.78175297 |
| 103 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.76721623 |
| 104 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.76015027 |
| 105 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.75960623 |
| 106 | MAF_26560356_Chip-Seq_TH2_Human | 0.73714270 |
| 107 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.72404510 |
| 108 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.71434664 |
| 109 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.70026231 |
| 110 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.69934856 |
| 111 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.65431339 |
| 112 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.64345594 |
| 113 | GATA1_22025678_ChIP-Seq_K562_Human | 0.62945851 |
| 114 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.61846331 |
| 115 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.59948468 |
| 116 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.58350131 |
| 117 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.56382954 |
| 118 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.54119099 |
| 119 | TP53_16413492_ChIP-PET_HCT116_Human | 0.54060675 |
| 120 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.52741079 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003436_decreased_susceptibility_to | 4.07762381 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.95153411 |
| 3 | MP0003303_peritoneal_inflammation | 3.81687570 |
| 4 | MP0002419_abnormal_innate_immunity | 3.54696500 |
| 5 | MP0005058_abnormal_lysosome_morphology | 3.45312625 |
| 6 | MP0000569_abnormal_digit_pigmentation | 3.04367568 |
| 7 | MP0009785_altered_susceptibility_to | 3.01995748 |
| 8 | MP0002148_abnormal_hypersensitivity_rea | 2.97538587 |
| 9 | MP0005464_abnormal_platelet_physiology | 2.94591528 |
| 10 | MP0006082_CNS_inflammation | 2.89298450 |
| 11 | MP0005000_abnormal_immune_tolerance | 2.81050535 |
| 12 | MP0003172_abnormal_lysosome_physiology | 2.73631985 |
| 13 | MP0009278_abnormal_bone_marrow | 2.72786990 |
| 14 | MP0005025_abnormal_response_to | 2.71649016 |
| 15 | MP0003183_abnormal_peptide_metabolism | 2.67319184 |
| 16 | MP0002452_abnormal_antigen_presenting | 2.59878901 |
| 17 | MP0003191_abnormal_cellular_cholesterol | 2.55762601 |
| 18 | MP0005671_abnormal_response_to | 2.49436546 |
| 19 | MP0001800_abnormal_humoral_immune | 2.42094438 |
| 20 | MP0002723_abnormal_immune_serum | 2.39744934 |
| 21 | MP0003724_increased_susceptibility_to | 2.29547564 |
| 22 | MP0005387_immune_system_phenotype | 2.28229008 |
| 23 | MP0001790_abnormal_immune_system | 2.28229008 |
| 24 | MP0001533_abnormal_skeleton_physiology | 2.27666920 |
| 25 | MP0001819_abnormal_immune_cell | 2.26922370 |
| 26 | MP0002420_abnormal_adaptive_immunity | 2.25548643 |
| 27 | MP0000343_altered_response_to | 2.14148037 |
| 28 | MP0000685_abnormal_immune_system | 2.13579289 |
| 29 | MP0001853_heart_inflammation | 2.02675905 |
| 30 | MP0003806_abnormal_nucleotide_metabolis | 2.02396785 |
| 31 | MP0002405_respiratory_system_inflammati | 2.02064998 |
| 32 | MP0003075_altered_response_to | 1.94742980 |
| 33 | MP0003300_gastrointestinal_ulcer | 1.87744346 |
| 34 | * MP0001845_abnormal_inflammatory_respons | 1.82852742 |
| 35 | MP0005174_abnormal_tail_pigmentation | 1.75701011 |
| 36 | MP0002396_abnormal_hematopoietic_system | 1.74708961 |
| 37 | MP0004510_myositis | 1.73677392 |
| 38 | MP0001545_abnormal_hematopoietic_system | 1.69385965 |
| 39 | MP0005397_hematopoietic_system_phenotyp | 1.69385965 |
| 40 | MP0001851_eye_inflammation | 1.65427787 |
| 41 | MP0000716_abnormal_immune_system | 1.64341455 |
| 42 | MP0004947_skin_inflammation | 1.62008892 |
| 43 | MP0002398_abnormal_bone_marrow | 1.57645571 |
| 44 | MP0009764_decreased_sensitivity_to | 1.57523072 |
| 45 | * MP0008469_abnormal_protein_level | 1.52497065 |
| 46 | MP0003448_altered_tumor_morphology | 1.48476587 |
| 47 | MP0010155_abnormal_intestine_physiology | 1.45302895 |
| 48 | MP0005167_abnormal_blood-brain_barrier | 1.43010900 |
| 49 | MP0003828_pulmonary_edema | 1.42903374 |
| 50 | MP0005310_abnormal_salivary_gland | 1.40815228 |
| 51 | MP0004808_abnormal_hematopoietic_stem | 1.40209568 |
| 52 | MP0000689_abnormal_spleen_morphology | 1.39740563 |
| 53 | MP0000465_gastrointestinal_hemorrhage | 1.37316894 |
| 54 | MP0000015_abnormal_ear_pigmentation | 1.37009396 |
| 55 | MP0002277_abnormal_respiratory_mucosa | 1.33802485 |
| 56 | MP0009840_abnormal_foam_cell | 1.32700734 |
| 57 | * MP0002429_abnormal_blood_cell | 1.32579480 |
| 58 | MP0003690_abnormal_glial_cell | 1.31680034 |
| 59 | MP0005075_abnormal_melanosome_morpholog | 1.29841093 |
| 60 | MP0005166_decreased_susceptibility_to | 1.29643959 |
| 61 | MP0000858_altered_metastatic_potential | 1.29565826 |
| 62 | MP0002722_abnormal_immune_system | 1.26211635 |
| 63 | MP0002933_joint_inflammation | 1.24822529 |
| 64 | MP0002132_abnormal_respiratory_system | 1.22698177 |
| 65 | MP0002998_abnormal_bone_remodeling | 1.21830224 |
| 66 | MP0009333_abnormal_splenocyte_physiolog | 1.17737121 |
| 67 | MP0001986_abnormal_taste_sensitivity | 1.17693098 |
| 68 | MP0004883_abnormal_blood_vessel | 1.15356670 |
| 69 | MP0001873_stomach_inflammation | 1.12723987 |
| 70 | MP0002006_tumorigenesis | 1.12548480 |
| 71 | MP0003566_abnormal_cell_adhesion | 1.11587207 |
| 72 | MP0002166_altered_tumor_susceptibility | 1.09020522 |
| 73 | MP0005390_skeleton_phenotype | 1.05081342 |
| 74 | MP0005451_abnormal_body_composition | 1.04247281 |
| 75 | MP0000604_amyloidosis | 1.03293349 |
| 76 | MP0002928_abnormal_bile_duct | 1.01570927 |
| 77 | MP0005076_abnormal_cell_differentiation | 0.98560333 |
| 78 | MP0005164_abnormal_response_to | 0.97177834 |
| 79 | MP0010307_abnormal_tumor_latency | 0.95275810 |
| 80 | MP0008004_abnormal_stomach_pH | 0.89098271 |
| 81 | MP0000371_diluted_coat_color | 0.87280002 |
| 82 | MP0000249_abnormal_blood_vessel | 0.81962193 |
| 83 | MP0003279_aneurysm | 0.81872796 |
| 84 | MP0005023_abnormal_wound_healing | 0.81689233 |
| 85 | MP0009765_abnormal_xenobiotic_induced | 0.80931027 |
| 86 | MP0009763_increased_sensitivity_to | 0.80787222 |
| 87 | MP0003453_abnormal_keratinocyte_physiol | 0.80518846 |
| 88 | MP0003656_abnormal_erythrocyte_physiolo | 0.78612104 |
| 89 | MP0006036_abnormal_mitochondrial_physio | 0.75905138 |
| 90 | MP0003195_calcinosis | 0.74783717 |
| 91 | MP0000767_abnormal_smooth_muscle | 0.73090417 |
| 92 | MP0000920_abnormal_myelination | 0.72241867 |
| 93 | MP0003646_muscle_fatigue | 0.69829408 |
| 94 | MP0000490_abnormal_crypts_of | 0.69613541 |
| 95 | MP0003795_abnormal_bone_structure | 0.69425510 |
| 96 | MP0000703_abnormal_thymus_morphology | 0.69213387 |
| 97 | MP0002254_reproductive_system_inflammat | 0.66825057 |
| 98 | MP0005535_abnormal_body_temperature | 0.66204765 |
| 99 | MP0003045_fibrosis | 0.63235714 |
| 100 | MP0003638_abnormal_response/metabolism_ | 0.62775076 |
| 101 | MP0002009_preneoplasia | 0.61404282 |
| 102 | MP0004381_abnormal_hair_follicle | 0.60858120 |
| 103 | MP0001663_abnormal_digestive_system | 0.60645806 |
| 104 | MP0004782_abnormal_surfactant_physiolog | 0.60058291 |
| 105 | MP0005084_abnormal_gallbladder_morpholo | 0.59641660 |
| 106 | MP0008260_abnormal_autophagy | 0.58706487 |
| 107 | * MP0005319_abnormal_enzyme/_coenzyme | 0.58146272 |
| 108 | MP0004147_increased_porphyrin_level | 0.57820838 |
| 109 | MP0001958_emphysema | 0.57653488 |
| 110 | MP0008873_increased_physiological_sensi | 0.56530753 |
| 111 | MP0005647_abnormal_sex_gland | 0.52677498 |
| 112 | MP0002693_abnormal_pancreas_physiology | 0.52119260 |
| 113 | MP0003866_abnormal_defecation | 0.51476063 |
| 114 | MP0002019_abnormal_tumor_incidence | 0.50886870 |
| 115 | MP0003763_abnormal_thymus_physiology | 0.50804314 |
| 116 | MP0002095_abnormal_skin_pigmentation | 0.50482402 |
| 117 | MP0005334_abnormal_fat_pad | 0.49185827 |
| 118 | MP0003091_abnormal_cell_migration | 0.44996195 |
| 119 | MP0001191_abnormal_skin_condition | 0.44181685 |
| 120 | MP0002136_abnormal_kidney_physiology | 0.42276313 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 8.50570158 |
| 2 | Eczematoid dermatitis (HP:0000976) | 8.03837467 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 7.75435007 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 6.65776046 |
| 5 | Systemic lupus erythematosus (HP:0002725) | 6.04437794 |
| 6 | Abnormality of macrophages (HP:0004311) | 5.14865852 |
| 7 | Recurrent skin infections (HP:0001581) | 4.69643712 |
| 8 | Mediastinal lymphadenopathy (HP:0100721) | 4.51730930 |
| 9 | Obstructive lung disease (HP:0006536) | 4.49524205 |
| 10 | Chronic obstructive pulmonary disease (HP:0006510) | 4.49524205 |
| 11 | Gingivitis (HP:0000230) | 4.46074718 |
| 12 | Glomerulonephritis (HP:0000099) | 4.42097055 |
| 13 | Vacuolated lymphocytes (HP:0001922) | 4.22638820 |
| 14 | Increased cerebral lipofuscin (HP:0011813) | 4.21385148 |
| 15 | Recurrent fungal infections (HP:0002841) | 4.18699989 |
| 16 | Myositis (HP:0100614) | 4.04283015 |
| 17 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.03093568 |
| 18 | Abnormality of glycolipid metabolism (HP:0010969) | 3.74037533 |
| 19 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.74037533 |
| 20 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.74037533 |
| 21 | Stomatitis (HP:0010280) | 3.65901071 |
| 22 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.51436966 |
| 23 | Dysostosis multiplex (HP:0000943) | 3.50118587 |
| 24 | Encephalitis (HP:0002383) | 3.47949734 |
| 25 | Gastrointestinal infarctions (HP:0005244) | 3.33269517 |
| 26 | Disinhibition (HP:0000734) | 3.25614740 |
| 27 | Cellulitis (HP:0100658) | 3.23778499 |
| 28 | Recurrent cutaneous fungal infections (HP:0011370) | 3.18116494 |
| 29 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.18116494 |
| 30 | Axonal loss (HP:0003447) | 3.14675707 |
| 31 | Periodontitis (HP:0000704) | 3.11726425 |
| 32 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.07310887 |
| 33 | Orchitis (HP:0100796) | 3.05256534 |
| 34 | Panhypogammaglobulinemia (HP:0003139) | 3.00593908 |
| 35 | Agnosia (HP:0010524) | 2.99266490 |
| 36 | Chest pain (HP:0100749) | 2.95629558 |
| 37 | Keratoconjunctivitis sicca (HP:0001097) | 2.94963641 |
| 38 | Meningitis (HP:0001287) | 2.92397113 |
| 39 | Hematochezia (HP:0002573) | 2.92176894 |
| 40 | Spontaneous hematomas (HP:0007420) | 2.85175186 |
| 41 | Urticaria (HP:0001025) | 2.84338398 |
| 42 | Keratoconjunctivitis (HP:0001096) | 2.82458696 |
| 43 | Pustule (HP:0200039) | 2.80792444 |
| 44 | Interstitial pulmonary disease (HP:0006530) | 2.75120069 |
| 45 | Retrobulbar optic neuritis (HP:0100654) | 2.75069413 |
| 46 | Optic neuritis (HP:0100653) | 2.75069413 |
| 47 | Osteomyelitis (HP:0002754) | 2.75021577 |
| 48 | Recurrent viral infections (HP:0004429) | 2.74588102 |
| 49 | Mucopolysacchariduria (HP:0008155) | 2.73747309 |
| 50 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.73747309 |
| 51 | Nephritis (HP:0000123) | 2.73422620 |
| 52 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.72217215 |
| 53 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.72217215 |
| 54 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.72217215 |
| 55 | Episodic fever (HP:0001954) | 2.66979753 |
| 56 | Prostate neoplasm (HP:0100787) | 2.61966857 |
| 57 | Abnormality of the prostate (HP:0008775) | 2.58315679 |
| 58 | Recurrent pneumonia (HP:0006532) | 2.56686333 |
| 59 | Vasculitis (HP:0002633) | 2.56380574 |
| 60 | Complement deficiency (HP:0004431) | 2.51919495 |
| 61 | Abnormality of complement system (HP:0005339) | 2.51428979 |
| 62 | Increased serum ferritin (HP:0003281) | 2.50004411 |
| 63 | Abnormality of T cell physiology (HP:0011840) | 2.48490190 |
| 64 | Abnormality of T cells (HP:0002843) | 2.46474286 |
| 65 | Leukocytosis (HP:0001974) | 2.45568687 |
| 66 | Hepatosplenomegaly (HP:0001433) | 2.43270045 |
| 67 | Colitis (HP:0002583) | 2.42098679 |
| 68 | Autoimmune thrombocytopenia (HP:0001973) | 2.41977814 |
| 69 | Anorexia (HP:0002039) | 2.40957188 |
| 70 | Inflammation of the large intestine (HP:0002037) | 2.39504179 |
| 71 | Prolonged bleeding time (HP:0003010) | 2.39346917 |
| 72 | Agammaglobulinemia (HP:0004432) | 2.38970694 |
| 73 | Thrombocytosis (HP:0001894) | 2.38148491 |
| 74 | Increased IgE level (HP:0003212) | 2.37666116 |
| 75 | Abnormality of the pleura (HP:0002103) | 2.37571108 |
| 76 | Pulmonary embolism (HP:0002204) | 2.36691107 |
| 77 | Abnormality of iron homeostasis (HP:0011031) | 2.35746823 |
| 78 | Purpura (HP:0000979) | 2.34179378 |
| 79 | Osteolytic defects of the hand bones (HP:0009699) | 2.33910224 |
| 80 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.33910224 |
| 81 | Gangrene (HP:0100758) | 2.33878088 |
| 82 | Basal ganglia calcification (HP:0002135) | 2.30161995 |
| 83 | Thick nail (HP:0001805) | 2.27995180 |
| 84 | Abnormality of T cell number (HP:0011839) | 2.26812251 |
| 85 | Arterial tortuosity (HP:0005116) | 2.26410983 |
| 86 | T lymphocytopenia (HP:0005403) | 2.26241729 |
| 87 | IgM deficiency (HP:0002850) | 2.25338401 |
| 88 | Cheilitis (HP:0100825) | 2.22353690 |
| 89 | Vertigo (HP:0002321) | 2.21835160 |
| 90 | Polyneuropathy (HP:0001271) | 2.21796544 |
| 91 | Gastrointestinal inflammation (HP:0004386) | 2.20666615 |
| 92 | Thoracic kyphosis (HP:0002942) | 2.20591057 |
| 93 | Amaurosis fugax (HP:0100576) | 2.20389551 |
| 94 | Thickened calvaria (HP:0002684) | 2.20224873 |
| 95 | Gingival bleeding (HP:0000225) | 2.20081598 |
| 96 | Epistaxis (HP:0000421) | 2.19449841 |
| 97 | Eosinophilia (HP:0001880) | 2.17564021 |
| 98 | Petechiae (HP:0000967) | 2.13990589 |
| 99 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.13836187 |
| 100 | Arterial thrombosis (HP:0004420) | 2.11850541 |
| 101 | Hemoptysis (HP:0002105) | 2.11697408 |
| 102 | Cerebral aneurysm (HP:0004944) | 2.09792817 |
| 103 | 3-Methylglutaconic aciduria (HP:0003535) | 2.07273890 |
| 104 | Pathologic fracture (HP:0002756) | 2.06758924 |
| 105 | Skin rash (HP:0000988) | 2.06705160 |
| 106 | Hypochromic anemia (HP:0001931) | 2.05710798 |
| 107 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.05679507 |
| 108 | Recurrent lower respiratory tract infections (HP:0002783) | 2.04496003 |
| 109 | Thyroiditis (HP:0100646) | 2.03144624 |
| 110 | Hypochromic microcytic anemia (HP:0004840) | 2.02875061 |
| 111 | Upper motor neuron abnormality (HP:0002127) | 2.02308522 |
| 112 | Impaired platelet aggregation (HP:0003540) | 2.01349203 |
| 113 | Abnormal platelet function (HP:0011869) | 2.01349203 |
| 114 | Pulmonary infiltrates (HP:0002113) | 2.00180769 |
| 115 | Increased IgM level (HP:0003496) | 1.98031903 |
| 116 | Loss of speech (HP:0002371) | 1.97112263 |
| 117 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.94150383 |
| 118 | Progressive visual loss (HP:0000529) | 1.93790391 |
| 119 | Fatigue (HP:0012378) | 1.93642655 |
| 120 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.93623686 |
| 121 | Spondylolisthesis (HP:0003302) | 1.93085458 |
| 122 | Chronic diarrhea (HP:0002028) | 1.91329001 |
| 123 | Mutism (HP:0002300) | 1.91005509 |
| 124 | Vascular tortuosity (HP:0004948) | 1.90742637 |
| 125 | Glomerulopathy (HP:0100820) | 1.90734261 |
| 126 | Global brain atrophy (HP:0002283) | 1.90502645 |
| 127 | Retinal atrophy (HP:0001105) | 1.90309412 |
| 128 | Sepsis (HP:0100806) | 1.89726913 |
| 129 | Bone pain (HP:0002653) | 1.88968921 |
| 130 | Myocardial infarction (HP:0001658) | 1.88588315 |
| 131 | Urethral obstruction (HP:0000796) | 1.85032270 |
| 132 | Abnormality of B cell number (HP:0010975) | 1.84393275 |
| 133 | Polycythemia (HP:0001901) | 1.82291294 |
| 134 | J-shaped sella turcica (HP:0002680) | 1.81976529 |
| 135 | Granulocytopenia (HP:0001913) | 1.81932996 |
| 136 | Thrombophlebitis (HP:0004418) | 1.81865622 |
| 137 | Amyloidosis (HP:0011034) | 1.81080086 |
| 138 | Abnormality of the thoracic spine (HP:0100711) | 1.79034861 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 4.45333443 |
| 2 | IRAK4 | 4.21591196 |
| 3 | TGFBR2 | 4.16415019 |
| 4 | BLK | 4.14314289 |
| 5 | MAP4K1 | 2.80569831 |
| 6 | CSF1R | 2.62072178 |
| 7 | IRAK3 | 2.51317862 |
| 8 | MAP3K14 | 2.41237938 |
| 9 | TYK2 | 2.27572754 |
| 10 | TBK1 | 2.20482197 |
| 11 | KIT | 2.17190041 |
| 12 | FES | 2.13775310 |
| 13 | EPHB1 | 2.11443455 |
| 14 | TXK | 2.08934478 |
| 15 | GRK7 | 2.08381244 |
| 16 | TEC | 1.92455975 |
| 17 | BTK | 1.88525099 |
| 18 | CAMK1D | 1.82643557 |
| 19 | CSK | 1.82538651 |
| 20 | HCK | 1.82346279 |
| 21 | STK10 | 1.74471476 |
| 22 | ZAP70 | 1.69424275 |
| 23 | TAOK3 | 1.66544236 |
| 24 | CLK1 | 1.59826717 |
| 25 | ERN1 | 1.59394357 |
| 26 | CDK19 | 1.59253293 |
| 27 | FGR | 1.51330399 |
| 28 | MAP2K3 | 1.47259544 |
| 29 | SYK | 1.42259974 |
| 30 | JAK1 | 1.37840611 |
| 31 | ITK | 1.37633482 |
| 32 | IKBKB | 1.37191042 |
| 33 | SIK2 | 1.34355095 |
| 34 | CAMK1G | 1.33894308 |
| 35 | TRPM7 | 1.28771085 |
| 36 | IKBKE | 1.25509506 |
| 37 | MAP3K13 | 1.24505844 |
| 38 | ADRBK2 | 1.22761287 |
| 39 | PAK4 | 1.18666529 |
| 40 | * LYN | 1.16832801 |
| 41 | JAK3 | 1.09359965 |
| 42 | MATK | 1.04002711 |
| 43 | YES1 | 1.03644669 |
| 44 | * LCK | 1.00712611 |
| 45 | PRPF4B | 0.98692458 |
| 46 | JAK2 | 0.98403866 |
| 47 | MARK3 | 0.98181595 |
| 48 | PTK6 | 0.96426476 |
| 49 | FLT3 | 0.95396198 |
| 50 | PKN2 | 0.92193754 |
| 51 | TAOK1 | 0.90125042 |
| 52 | MAPK15 | 0.89083124 |
| 53 | NEK9 | 0.88195444 |
| 54 | DAPK2 | 0.88170710 |
| 55 | TTN | 0.85234451 |
| 56 | PIM1 | 0.77536030 |
| 57 | ACVR1B | 0.74919988 |
| 58 | EIF2AK2 | 0.74509328 |
| 59 | IRAK1 | 0.74384306 |
| 60 | MAP3K10 | 0.70054695 |
| 61 | GRK6 | 0.68882810 |
| 62 | RPS6KA4 | 0.68818962 |
| 63 | PIK3CG | 0.68134013 |
| 64 | TLK1 | 0.66641142 |
| 65 | MOS | 0.64181784 |
| 66 | PRKCQ | 0.63630077 |
| 67 | CDK12 | 0.63597189 |
| 68 | MAPKAPK2 | 0.62971992 |
| 69 | CHUK | 0.61300783 |
| 70 | PRKCD | 0.60326288 |
| 71 | PDK1 | 0.59963729 |
| 72 | CAMKK2 | 0.59129284 |
| 73 | TRIB3 | 0.59104099 |
| 74 | SIK3 | 0.56002128 |
| 75 | MAP2K6 | 0.55442285 |
| 76 | FRK | 0.54840909 |
| 77 | TAOK2 | 0.52915883 |
| 78 | ABL1 | 0.52859056 |
| 79 | STK4 | 0.52034464 |
| 80 | MARK2 | 0.50277347 |
| 81 | PDPK1 | 0.50219310 |
| 82 | NME2 | 0.49078345 |
| 83 | PRKG2 | 0.48896353 |
| 84 | LRRK2 | 0.47810875 |
| 85 | ERBB3 | 0.46790051 |
| 86 | CDK6 | 0.46788571 |
| 87 | MAP3K3 | 0.45792581 |
| 88 | MAPK12 | 0.45399827 |
| 89 | INSRR | 0.44944651 |
| 90 | HIPK2 | 0.44575193 |
| 91 | TESK2 | 0.44339086 |
| 92 | MAPK4 | 0.44215652 |
| 93 | RPS6KA2 | 0.43989125 |
| 94 | KDR | 0.43408295 |
| 95 | PTK2B | 0.42782638 |
| 96 | FYN | 0.40999303 |
| 97 | MAP3K6 | 0.40965618 |
| 98 | MAPK7 | 0.40482055 |
| 99 | CAMKK1 | 0.39958746 |
| 100 | RPS6KA6 | 0.38468046 |
| 101 | MAP3K11 | 0.38170113 |
| 102 | BCKDK | 0.38168187 |
| 103 | MAP3K2 | 0.37265374 |
| 104 | ALK | 0.36946293 |
| 105 | DYRK1B | 0.36854930 |
| 106 | DMPK | 0.36718113 |
| 107 | OXSR1 | 0.36646095 |
| 108 | BMPR2 | 0.35892987 |
| 109 | PRKAA2 | 0.32812173 |
| 110 | PRKD2 | 0.32603935 |
| 111 | * EGFR | 0.32581795 |
| 112 | RPS6KC1 | 0.32475991 |
| 113 | RPS6KL1 | 0.32475991 |
| 114 | IRAK2 | 0.31878519 |
| 115 | MAP3K5 | 0.31533045 |
| 116 | MAP2K2 | 0.30824719 |
| 117 | CAMK4 | 0.30771524 |
| 118 | MAP4K2 | 0.30552406 |
| 119 | MAP3K9 | 0.30527961 |
| 120 | IGF1R | 0.30297934 |
| 121 | STK11 | 0.30114322 |
| 122 | CDK4 | 0.28539496 |
| 123 | TGFBR1 | 0.26381345 |
| 124 | STK24 | 0.26058770 |
| 125 | SGK3 | 0.25851336 |
| 126 | MAPK11 | 0.24444922 |
| 127 | TNK2 | 0.22781450 |
| 128 | EEF2K | 0.22257093 |
| 129 | STK3 | 0.21313803 |
| 130 | PRKCH | 0.20860936 |
| 131 | MAP3K1 | 0.19991329 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 4.14550907 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 3.53859554 |
| 3 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.87655464 |
| 4 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.62978944 |
| 5 | Other glycan degradation_Homo sapiens_hsa00511 | 2.59463539 |
| 6 | Pertussis_Homo sapiens_hsa05133 | 2.40777887 |
| 7 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.36226798 |
| 8 | Tuberculosis_Homo sapiens_hsa05152 | 2.25598415 |
| 9 | Lysosome_Homo sapiens_hsa04142 | 2.21521731 |
| 10 | Legionellosis_Homo sapiens_hsa05134 | 2.21085982 |
| 11 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.06714182 |
| 12 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.00357437 |
| 13 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.94528328 |
| 14 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.89894967 |
| 15 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.77926759 |
| 16 | Phagosome_Homo sapiens_hsa04145 | 1.76657203 |
| 17 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.75087001 |
| 18 | Malaria_Homo sapiens_hsa05144 | 1.75080444 |
| 19 | Asthma_Homo sapiens_hsa05310 | 1.64658364 |
| 20 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.61717161 |
| 21 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.60027571 |
| 22 | * Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.58857879 |
| 23 | Measles_Homo sapiens_hsa05162 | 1.58846856 |
| 24 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.57915813 |
| 25 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.57398731 |
| 26 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.55029629 |
| 27 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.53724399 |
| 28 | Salmonella infection_Homo sapiens_hsa05132 | 1.52743805 |
| 29 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.50326956 |
| 30 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.48307872 |
| 31 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.46083228 |
| 32 | Influenza A_Homo sapiens_hsa05164 | 1.39946919 |
| 33 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.38372851 |
| 34 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.37948910 |
| 35 | Allograft rejection_Homo sapiens_hsa05330 | 1.35420648 |
| 36 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.34287311 |
| 37 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.33761272 |
| 38 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.25104499 |
| 39 | Shigellosis_Homo sapiens_hsa05131 | 1.15803719 |
| 40 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.12532571 |
| 41 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.12021487 |
| 42 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.12007479 |
| 43 | Apoptosis_Homo sapiens_hsa04210 | 1.11318903 |
| 44 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.11300282 |
| 45 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.06994458 |
| 46 | Platelet activation_Homo sapiens_hsa04611 | 1.06333986 |
| 47 | Hepatitis B_Homo sapiens_hsa05161 | 1.05486990 |
| 48 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.02775292 |
| 49 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.99607304 |
| 50 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.99065810 |
| 51 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.97480925 |
| 52 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.97291049 |
| 53 | Amoebiasis_Homo sapiens_hsa05146 | 0.92585317 |
| 54 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.92428907 |
| 55 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.89220776 |
| 56 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.88865684 |
| 57 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.84858923 |
| 58 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.82066529 |
| 59 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.81862594 |
| 60 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.79344067 |
| 61 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.73730929 |
| 62 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.72376425 |
| 63 | Viral myocarditis_Homo sapiens_hsa05416 | 0.70901703 |
| 64 | Hepatitis C_Homo sapiens_hsa05160 | 0.68947547 |
| 65 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.68495974 |
| 66 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.66563630 |
| 67 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.64080951 |
| 68 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.62847381 |
| 69 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.61739688 |
| 70 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.61482933 |
| 71 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.61292788 |
| 72 | Prion diseases_Homo sapiens_hsa05020 | 0.60571135 |
| 73 | Endocytosis_Homo sapiens_hsa04144 | 0.60138430 |
| 74 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.59993632 |
| 75 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.59454606 |
| 76 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.54153785 |
| 77 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.51558670 |
| 78 | ABC transporters_Homo sapiens_hsa02010 | 0.51252481 |
| 79 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.48908356 |
| 80 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.46685749 |
| 81 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.45579223 |
| 82 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.45098543 |
| 83 | Ribosome_Homo sapiens_hsa03010 | 0.45009737 |
| 84 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.42947574 |
| 85 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.42811011 |
| 86 | Colorectal cancer_Homo sapiens_hsa05210 | 0.41691621 |
| 87 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.41313971 |
| 88 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.39010042 |
| 89 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.38036815 |
| 90 | Parkinsons disease_Homo sapiens_hsa05012 | 0.37726003 |
| 91 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.36507781 |
| 92 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.36018408 |
| 93 | Insulin resistance_Homo sapiens_hsa04931 | 0.35835513 |
| 94 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.35657852 |
| 95 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.35515080 |
| 96 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.34802818 |
| 97 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.34690799 |
| 98 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.34634068 |
| 99 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.33209221 |
| 100 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.32791160 |
| 101 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.31987564 |
| 102 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.31318440 |
| 103 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.30332876 |
| 104 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.29989040 |
| 105 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.29759879 |
| 106 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.29647247 |
| 107 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.29565312 |
| 108 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.27075954 |
| 109 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.26838361 |
| 110 | HTLV-I infection_Homo sapiens_hsa05166 | 0.26081007 |
| 111 | Glioma_Homo sapiens_hsa05214 | 0.25858354 |
| 112 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.23960210 |
| 113 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.22702074 |
| 114 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.20546049 |
| 115 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.19563889 |
| 116 | Alzheimers disease_Homo sapiens_hsa05010 | 0.18309939 |
| 117 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.17069469 |
| 118 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.14376618 |
| 119 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.13807270 |
| 120 | Olfactory transduction_Homo sapiens_hsa04740 | 0.12194339 |
| 121 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.12099480 |
| 122 | Bladder cancer_Homo sapiens_hsa05219 | 0.11007060 |
| 123 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.08204434 |
| 124 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.06110847 |

